<DOC>
	<DOC>NCT02841891</DOC>
	<brief_summary>The Cohera Sylys® Surgical Sealant study is a prospective, randomized, controlled, multicenter technical feasibility clinical study comparing standard anastomosis closure technique (Control) to standard closure techniques plus Sylys® Surgical Sealant (Test) during colorectal and ileorectal anastomosis procedures.</brief_summary>
	<brief_title>A Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Techniques Plus Sylys® Surgical Sealant</brief_title>
	<detailed_description />
	<criteria>Be at least 22 years of age Be scheduled for a colorectal or ileorectal anastomosis procedure with a diverting stoma Agree to return for all followup evaluations and procedures specified in the protocol Understand and give informed consent Albumin &lt; 3 g/dL ASA score (American Society of Anesthesiologists) ≥ 4 Neutropenia ≤ 800 cells/μl Pregnancy The following conditions involving compromised immune system: AIDS (HIV positive not excluded), neutropenia Known blood clotting disorder requiring treatment Have known or suspected allergy or sensitivity to any test materials or reagents Concurrent use of fibrin sealants or other anastomosis care devices Surgery for emergency abdominal indications Patients who have undergone prior colorectal anastomosis surgery in the previous two months, or are receiving an additional anastomosis related to complications from a previous anastomosis procedure Stage 1 (First 20 patients) Only (High Risk Cancer Patients): Lymph Node Cancer Stage: N2 Cancer Tumor Size: T4 Circumferential resection margin: CRM+ (Positive)</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>